期刊文献+

术前区域性动脉灌注化疗对晚期乳腺癌MVD、MLVD的影响

Effects of preoperative local intra-arterial infusion chemotherapy on MVD and MLVD in advanced breast cancer
下载PDF
导出
摘要 目的探讨术前区域性动脉灌注化疗对晚期乳腺癌微血管密度(MVD)、微淋巴管密度(MLVD)的影响。方法将76例晚期乳腺癌随机分为两组,术前局部动脉灌注化疗(A组)35例和术前全身静脉化疗(B组)41例,另选25例未行术前化疗的Ⅲ期乳腺癌作对照组。采用免疫组化SP法,用CD34、血管内皮生长因子受体3(VEGFR3)抗体对3组组织标本进行MVD、MLVD检测。结果A组MVD为36.05±13.64,B组为49.92±12.90,对照组为60.38±13.54,各组间比较差异均有高度显著性(P<0.01);A组MLVD为6.62±3.70,B组为9.96±4.57,对照组为11.30±5.32,A组与对照组、B组比较差异有高度显著性(P<0.01),B组与对照组比较差异无显著性(P>0.05)。结论术前区域性动脉灌注化疗能有效地降低肿瘤组织及其周边组织内MVD和MLVD,从而抑制肿瘤细胞生长,减少肿瘤转移的机会。 Objective To outline the effects of preoperative intra- arterial infusion chemotherapy on microvessel density (MVD) and microlymphatic vessel density (MLVD) in advanced breast cancer. Methods 76 patients with advanced breast cancer were randomly divided into two groups: group A (preoperative local intra-arterial infusion chemotherapy group, n = 35) and group B (preoperative intra- venous infusion chemotherapy group, n = 41), 25 patients with stage Ⅲ advanced breast cancer without receiving preoperative chemotherapy were selected as control. An S - P immunohistochemistry method was used to measure MVD and MLVD in the tumor tissues of the three groups. The antibodies including CD34 and vascular endothelial growth factor receptor 3 (VEGFR3) antibody. Results ①The tumor mierovessel counts (i. e. MVD) in group A were 36.05 ± 13.64, in group B were 49.92± 12. 90, and in control group were 60.38 ± 13.54. In comparison among these three groups, there were statistically significant differences ( P 〈0.01). The tumor microlymphatic vessel counts (i. e. MLVD) in group A were 6.62 ± 3. 70, group B were 9.96 ± 4.57, and control group were 11.30 ± 5.32. Microlymphatie vessel counts in group A compared with group B and control group, there were statistically significant differences ( P〈0.01); in comparison of group B with control group, there was no statistical difference ( P 〉0.05). - arterial infusion chemotherapy can effectively lessen the MVD and MLVD sues, so it can inhibit the tumor cell growing and metastasis. Conclusion Preoperative local intra in tumor tissues and its peripheral tissues, so it can inhibit the tumor cell growing and metastasis.
出处 《右江民族医学院学报》 2007年第2期166-169,共4页 Journal of Youjiang Medical University for Nationalities
关键词 乳腺肿瘤 动脉灌注化疗 微血管密度 淋巴管密度 breast neoplasms intra - arterial infusion chemotherapy microvessel density lymphatic vessel density
  • 相关文献

参考文献5

二级参考文献29

  • 1彭勇,邹利光,席道友.乳腺癌的介入治疗8例报告[J].第三军医大学学报,1994,16(4):300-303. 被引量:6
  • 2柳金彬.Ⅲ期乳腺癌应用动脉导管灌注的新辅助化疗[J].实用肿瘤学杂志,1995,9(3):53-54. 被引量:13
  • 3陈治 黄宗海.VEGF-B和VEGF-C的研究进展[J].国外医学:生理病理科学与临床分册,1999,19(6):479-481.
  • 4Poltorak Z, Cohen T, Sivan R, et al. VEGF145, a secreted vascular endothelia growth factor isoform that binds to extracellular matrix. J Biol Chem, 1997, 272:7151-7158.
  • 5Ferrara N, Gerber H P, LeCouter J The biology of VEGF and its receptors. Nat Med, 2003, 9(6): 669-676.
  • 6Eichmann A, Corbel C, Jaffredo T, et al. Avian VEGF-C:cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors. Development, 1998, 125:743-752.
  • 7Park J E, Chen H H, Winter J, et al. Placenta growth factor.Potentiation of vascular endothelial growth factor bioactivity,in vitro and in vivo, and high affinity binding to Flt- 1 but not to FIk-1/KDR. JBiol Chem, 1994, 269:25646-25654.
  • 8Gille H, Kowalski J, Yu L L, et al. A repressor sequence in the juxtamembrane domain of FIt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth fator-dependent phosphatidylinositol 3 kinase activation and endothelial cell migration. EMBO J, 2000, 19:4064-4073.
  • 9Fong G H, Zhang L Y, Bryce D M, et al. Increased hemangioblast commitment, not vascular disorganized, is the primary defect in fIt- 1 knock-out mice. Development,1999, 126:3015-3025.
  • 10Hiratsuka S, Minowa O, Kuno J, et al. FIt- 1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA, 1998, 4:9349-0354.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部